Investigation of the Relationship Between Peripheral and Central Metabolic Changes Caused by Fasting
Meta-Fast
1 other identifier
interventional
12
1 country
1
Brief Summary
Fasting has become an increasingly popular intervention for improving both physical and mental health. This study aims to explore the biological mechanisms underlying the positive effects of low caloric fasting (Wilhelmi-Buchinger-fasting). Specifically, we focus on the metabolic transition from glucose to fat utilization and its effects on systemic and brain metabolism. By examining the relationship between peripheral metabolic changes and brain metabolism, this research aims to uncover how these shifts influence brain metabolism and behaviour.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Oct 2024
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 28, 2024
CompletedFirst Submitted
Initial submission to the registry
January 17, 2025
CompletedFirst Posted
Study publicly available on registry
September 17, 2025
CompletedSeptember 17, 2025
September 1, 2025
2 months
January 17, 2025
September 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MR spectroscopy
metabolites between 0-4 ppm in regions including the posterior cingulate cortex (PCC), medial cingulate cortex (MCC), and anterior insula
Outcome measures are assessed as changes from baseline over 3 fasting days, with follow-up on day 4 during refeeding, during a one-week on-site visit per participant, within an overall study period of 2 months
Secondary Outcomes (20)
Structural MR imaging
Outcome measures are assessed as changes from baseline over 3 fasting days, with follow-up on day 4 during refeeding, during a one-week on-site visit per participant, within an overall study period of 2 months
Functional MRI
Outcome measures are assessed as changes from baseline over 3 fasting days, with follow-up on day 4 during refeeding, during a one-week on-site visit per participant, within an overall study period of 2 months
Exploratory Proteomics of Autophagy Processes II
Outcome measures are assessed as changes from baseline over 3 fasting days, with follow-up on day 4 during refeeding, during a one-week on-site visit per participant, within an overall study period of 2 months
Exploratory Proteomics of Autophagy Processes I
Outcome measures are assessed as changes from baseline over 3 fasting days, with follow-up on day 4 during refeeding, during a one-week on-site visit per participant, within an overall study period of 2 months
Neuropsychology: Verbal Fluency
Outcome measures are assessed as changes from baseline over 3 fasting days, with follow-up on day 4 during refeeding, during a one-week on-site visit per participant, within an overall study period of 2 months
- +15 more secondary outcomes
Study Arms (1)
Participant Group/ Arm
EXPERIMENTALHealthy participants
Interventions
Participants undergo the standardised Wilhelmi-Buchinger fasting intervention, which consists of two days of preparation with a dietary energy supply of \<1000 kcal, three days of fasting with a dietary energy supply of 300-500 kcal with tea, broth, fruit and vegetable juices, and two days of recovery.
Eligibility Criteria
You may qualify if:
- Generally good physical condition without serious previous illnesses
- For female participants, only participants taking hormonal contraception are included
You may not qualify if:
- MRI contraindication: cardiac pacemakers, hearing aids, neurostimulation, insulin pumps, other potentially ferromagnetic implants, screws, clips, prostheses, metal splinters, etc., pregnancy, claustrophobia, extensive tattoos, medication that impairs thermoregulation
- Comorbidity: neurological or psychiatric conditions, cognitive impairments, chronic somatic disorders
- Intake of more than 40g of pure alcohol (for men) or more than 20g of pure alcohol (for women), smoking, regular drug use
- Pregnancy or nursing
- Current or within the past five years eating disorder, vegan diet or fasting within the past six months
- Regular medication intake
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nils Opellead
- University Hospital, Bonncollaborator
- Johann Wolfgang Goethe University Hospitalcollaborator
Study Sites (1)
Department of Psychiatry and Psychotherapy, University Hospital Jena
Jena, Thuringia, 07743, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sharmili Edwin Thanarajah, PD Dr med
Goethe University
- PRINCIPAL INVESTIGATOR
Nils Gassen, Prof Dr
University Hospital, Bonn
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof Dr med
Study Record Dates
First Submitted
January 17, 2025
First Posted
September 17, 2025
Study Start
October 4, 2024
Primary Completion
November 28, 2024
Study Completion
November 28, 2024
Last Updated
September 17, 2025
Record last verified: 2025-09